SCHEMBL12374079

SCHEMBL12374079

O=[N+]([O-])c1ccc(O)nc1Oc1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIN1 Q13526 4/20 0.57
MERTK Q12866 1/20 0.50
KMT2A Q03164 5/20 0.46
MEN1 O00255 4/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
ATM Q13315 1/20 0.46
TTR P02766 1/20 0.44
ALB P02768 1/20 0.44
THRB P10828 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
GPR35 Q9HC97 1/20 0.41
ALDH1A1 P00352 3/20 0.41
CTSB P07858 1/20 0.40
HPSE Q9Y251 1/20 0.39
CRHBP P24387 1/20 0.39
CRHR2 Q13324 1/20 0.39
XDH P47989 1/20 0.39
MAPT P10636 2/20 0.39
HTR6 P50406 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21494712 0.82 PIN1 (0.55) PIN1MERTKKMT2AMEN1NPC1
SCHEMBL12374077 0.81 PIN1 (0.57) PIN1MERTKKMT2AMEN1NPC1
SCHEMBL1308013 0.77 ALDH1A1 (0.45) PIN1MERTKKMT2AATMTDP1
SCHEMBL27175935 0.77 MERTK (0.48) PIN1MERTKRAB9ATDP1GPR35
SCHEMBL29674894 0.74 PIN1 (0.56) PIN1MERTKKMT2AMEN1NPC1
SCHEMBL242653 0.74 KMT2A (0.74) PIN1KMT2AMEN1NPC1RAB9A
SCHEMBL11036294 0.74 PIN1 (0.56) PIN1MERTKKMT2AMEN1NPC1
SCHEMBL12620328 0.73 PIN1 (1.00) PIN1MERTKMAPT
Acetic Acid SCHEMBL4766209 0.72 ALDH1A1 (0.67) PIN1KMT2AMEN1NPC1RAB9A
Acetic Acid SCHEMBL4766215 0.72 ALDH1A1 (0.67) PIN1KMT2AMEN1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110200535-A1 DAA-PYRIDINE AS PERIPHERAL BENZODIAZEPINE RECEPTOR LIGAND FOR DIAGNOSTIC IMAGING AND PHARMACEUTICAL TREATMENT BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2011-08-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110200535-A1 DAA-PYRIDINE AS PERIPHERAL BENZODIAZEPINE RECEPTOR LIGAND FOR DIAGNOSTIC IMAGING AND PHARMACEUTICAL TREATMENT GABRA6, GABRA4, GABRA1 PIN1 3534/4885MERTK 1024/4885KMT2A 702/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.